“A Randomized Controlled Trial Comparing Vonoprazan and Proton Pump Inhibitors for Symptom Relief and Mucosal Healing in Scleroderma-Associated GERD” (2025) Journal of Carcinogenesis, 24(8s), pp. 542–546. doi:10.64149/J.Carcinog.24.8s.542-546.